Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead [...]
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead [...]
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and [...]
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal [...]
Partnership will deliver AI-guided end-to-end workflow to access challenging membrane [...]
Enhancing patient treatment experience and care with a new self-administered [...]
Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for [...]
Automated workflow to be highlighted at SLAS 2026, 7-11 February, [...]
Access to automated instrumentation will enhance precision testing and improve [...]
Collaboration heralds new era of assay development in drug discovery [...]
HERCULES, Calif. — February 6 2026 — Bio-Rad Laboratories, Inc. (NYSE: [...]